Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer

Fluoropyrimidine-based chemotherapy (CT) has been the mainstay of care of metastatic colorectal cancer (mCRC) for years. Response rates are only observed, however, in about half of treated patients, and there are no reliable tools to prospectively identify patients more likely to benefit from therap...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Estevez-Garcia, Purificacion, Rivera, Fernando, Molina-Pinelo, Sonia, Benavent, Marta, Gómez, Javier, Limón, Maria Luisa, Pastor, Maria Dolores, Martinez-Perez, Julia, Paz-Ares, Luis, Carnero, Amancio, Garcia-Carbonero, Rocio
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4467428/
https://ncbi.nlm.nih.gov/pubmed/25730906
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items